评估慢性病风险的降低:一个大规模的多国声明偏好方法
Chris Dockins1, Damien Dussaux2, Charles Griffiths1
1U.S. Environmental Protection Agency, Washington, DC, USA.
概括
这项研究估计了公众愿意支付减少慢性病风险的费用. 调查结果为环境法规和公共卫生效益成本分析提供了关键的经济价值.
科学领域:
- 环境健康 环境健康
- 卫生经济学 卫生经济学
- 毒理学 毒理学 毒理学
背景情况:
- 功能受损与环境污染物有关,需要采取监管措施.
- 对于病影响,经济估值数据有限,阻碍了效益成本分析.
- 经合组织项目旨在改善化学品监管的经济评估.
研究的目的:
- 估计支付意愿 (WTP) 降低症状慢性病风险.
- 为了填补脏发病率评估文献中的一个空白.
- 为化学品法规的效益成本分析提供数据.
主要方法:
- 在10个国家进行了一项声明偏好调查.
- 参与者被问及他们的WTP,以减少严重病的风险.
- 数据是从代表性的国家样本中收集的.
主要成果:
- 在5年内,平均WTP将严重病风险降低3.5/1,000,为2,609美元.
- 慢性病的统计病例 (VSC) 的平均值为805,000美元.
- VSC的估计范围从加拿大的70万美元到土耳其的12亿美元.
结论:
- 这项研究为慢性病风险降低提供了新的WTP估计.
- 这些发现支持对环境和化学法规的经济评估.
- 评估数据对于做出明智的公共卫生政策决策至关重要.
关键词:
D61 D61 D61 D61 这是一个很好的例子.在I1818年,J17 J17 J17 J17 J17 J17 J17 J17 J17 J17 J17 J17 J17 J17 J17 J17K32 K32 K32 K32 K32 K32 K32 K32 K32 K32 K32 K32 K32 K32 K32 K32Q51 一个问题Q53 一个问题Q58Q58 Q58Q58 Q58Q58 Q58 Q58 Q58 Q58 Q58 Q58 Q58 Q58 Q58 Q58 Q58 Q58 Q58 Q58 Q58 Q58 Q58 Q58危害健康的风险健康评估健康评价脏疾病 脏疾病声明了自己的偏好.愿意支付的意愿.相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
36
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
36
Renal Failure: Dose Adjustments
38
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
38
Antihypertensive Drugs: Direct Renin Inhibitors
454
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
454
Determination of Renal Drug Clearance: Graphical and Midpoint Methods
58
Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
58
Drug Elimination by Renal Route: Glomerular Filtration
5.2K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
5.2K
Renal Drug Clearance: Overview
85
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
85


